Skip to content
Home/Companies/Biotech/GFBiochemicals
GFBiochemicals

GFBiochemicals

Biotech·France·Active·10yr hold
Entry
2016
Hold
10yr
Status
Active

Who owns GFBiochemicals?

GFBiochemicals is a French Biotech company, currently owned by Sofinnova Partners since 2016.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Sofinnova Partners
Investor
Sofinnova Partners
Sofinnova Industrial Biotech · 2018 · VC

Key facts

HQFrance
SectorBiotech
Websitewww.gfbiochemicals.com

More from Sofinnova Industrial Biotech

Other portfolio companies in the same fund.

P2 Science
P2 Science
Active
IndustrialsUnited States· 2026
Arzeda
Arzeda
Active
BiotechUS· 2022
IB Works I
Exited 2024
SoftwareFrance· 2022
Prometheus Materials
Prometheus Materials
Active
BiotechUS· 2022
Novameat
Novameat
Active
BiotechSpain· 2021
Qorium
Qorium
Active
BiotechNetherlands· 2021

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns GFBiochemicals?

GFBiochemicals is currently owned by Sofinnova Partners, through Sofinnova Industrial Biotech, since 2016.

When did Sofinnova Partners acquire GFBiochemicals?

Sofinnova Partners acquired GFBiochemicals in 2016.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue